WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)
South Korea · Delayed Price · Currency is KRW 8,820.00
-50.00 (-0.56%)
At close: Aug 24, 2026
KOSDAQ:330350 Market Cap
KOSDAQ:330350 has a market cap or net worth of 116.42 billion as of August 24, 2026. Its market cap has increased by 21.30% in one year.
Market Cap
116.42B
Enterprise Value
116.26B
Revenue
108.89B
Ranking
n/a
PE Ratio
15.97
Stock Price
8,820.00
ChartMarket Cap Chart
Since July 3, 2020, KOSDAQ:330350's market cap has decreased from 302.46B to 116.42B, a decrease of -61.51%. That is a compound annual growth rate of -14.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 116.42B | 2.30% |
| Dec 30, 2025 | 113.80B | 22.44% |
| Dec 30, 2024 | 92.94B | -27.60% |
| Dec 28, 2023 | 128.37B | 3.84% |
| Dec 29, 2022 | 123.62B | -10.73% |
| Dec 30, 2021 | 138.48B | -26.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CellBion | 165.06B |
| GC WellBeing | 151.01B |
| Kyung Dong Pharmaceutical | 136.06B |
| PHARMARESEARCH BIO | 131.48B |
| High Tech Pharm | 124.62B |
| HYUNDAI BIOLAND | 120.75B |
| Ahn-Gook Pharmaceutical | 117.86B |
| DongKoo Bio & Pharma | 99.79B |